Drug Pricing

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, released the following statement on the launch of TrumpRx, a new direct-to-consumer prescription drug platform launched by the Trump Administration:  “TrumpRx is yet another PR stunt and a money-making scheme for the Trump family. American seniors and patients will (once again) be left…

As Drug Prices Continue to Go Up and Republicans Give Hand Outs to Big Pharma, Democrats Offer Bold Vision to Lower Drug Costs for All Americans WASHINGTON, D.C. — Today, U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, joined Ranking Member of the Senate Finance…

Senators request answers on structure of “TrumpRx” and how recent drug pricing agreements will impact Medicare and Medicaid benefits  WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, this week led six Senate Democrats in demanding transparency from the…

WASHINGTON, D.C.—Finance Committee members Senator Peter Welch (D-Vt.) and Catherine Cortez Masto (D-Nev.), alongside Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today introduced the No Big Blockbuster Bailouts Act (NOBBBA), a bill to reverse Republicans’ policies in the so-called ‘One Big Beautiful Bill Act’…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) today joined U.S. Senators John Cornyn (R-Texas), Jacky Rosen (D-Nev.), and Thom Tillis (R-N.C.) in introducing the Share the Savings with Seniors Act of 2025, which would lower out-of-pocket prescription drug costs for seniors with chronic health…